MX168179B - Metodo mejorado para conjugar metalotioneina en moleculas biologicamente activas - Google Patents

Metodo mejorado para conjugar metalotioneina en moleculas biologicamente activas

Info

Publication number
MX168179B
MX168179B MX002075A MX207586A MX168179B MX 168179 B MX168179 B MX 168179B MX 002075 A MX002075 A MX 002075A MX 207586 A MX207586 A MX 207586A MX 168179 B MX168179 B MX 168179B
Authority
MX
Mexico
Prior art keywords
conjugating
biologically active
metalotioneine
improved method
active molecules
Prior art date
Application number
MX002075A
Other languages
English (en)
Inventor
Richard Albert Hadjian
Cynthia Ann Drozynshi
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of MX168179B publication Critical patent/MX168179B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a un método mejorado para conjugar metalotioneinas en moléculas binlógicamente activas, caracterizado porque consiste de los pasos de secuencia de (i) conjugar la MBA en un agente de reticulación heterobifuncional; y (ii) conjugar el producto de (i) con metalotioneina en donde por lo menos una porción del metal en la metalotioneina es un metal trazador.
MX002075A 1985-04-03 1986-04-03 Metodo mejorado para conjugar metalotioneina en moleculas biologicamente activas MX168179B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71943685A 1985-04-03 1985-04-03

Publications (1)

Publication Number Publication Date
MX168179B true MX168179B (es) 1993-05-10

Family

ID=24890070

Family Applications (1)

Application Number Title Priority Date Filing Date
MX002075A MX168179B (es) 1985-04-03 1986-04-03 Metodo mejorado para conjugar metalotioneina en moleculas biologicamente activas

Country Status (15)

Country Link
EP (1) EP0196669B1 (es)
JP (1) JPS61236733A (es)
KR (1) KR930003312B1 (es)
AT (1) ATE72569T1 (es)
AU (1) AU603981B2 (es)
DE (1) DE3683861D1 (es)
DK (1) DK148586A (es)
ES (1) ES8800437A1 (es)
FI (1) FI861424A (es)
GR (1) GR860876B (es)
IE (1) IE58425B1 (es)
IL (1) IL78377A0 (es)
MX (1) MX168179B (es)
NO (1) NO167124C (es)
ZA (1) ZA862417B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
US5194594A (en) * 1990-09-07 1993-03-16 Techniclone, Inc. Modified antibodies
CA2048078A1 (en) * 1990-11-15 1992-05-16 Wolfgang A. Wrasidlo Chemical modification of antibodies for creation of immunoconjugates
ATE197767T1 (de) * 1992-01-03 2000-12-15 Rhomed Inc Pharmazeutische anwendungen auf der basis von peptid-metall-ionen
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
CN1314966C (zh) * 2004-12-03 2007-05-09 湖南农业大学 一种猪金属硫蛋白的检测方法
JP5202443B2 (ja) * 2009-06-01 2013-06-05 興和株式会社 有害金属測定試薬及び測定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JP2871813B2 (ja) * 1990-07-03 1999-03-17 古河電気工業株式会社 クロスヘッドの角度調整装置

Also Published As

Publication number Publication date
DK148586A (da) 1986-10-04
GR860876B (en) 1986-07-29
NO167124C (no) 1991-10-09
EP0196669A3 (en) 1988-09-14
ES8800437A1 (es) 1987-10-16
IE860853L (en) 1986-10-03
DK148586D0 (da) 1986-04-02
ZA862417B (en) 1987-12-30
NO861200L (no) 1986-10-06
JPS61236733A (ja) 1986-10-22
AU603981B2 (en) 1990-12-06
EP0196669B1 (en) 1992-02-12
KR860008203A (ko) 1986-11-12
KR930003312B1 (ko) 1993-04-26
IE58425B1 (en) 1993-09-22
ES553685A0 (es) 1987-10-16
IL78377A0 (en) 1986-07-31
FI861424A (fi) 1986-10-04
NO167124B (no) 1991-07-01
EP0196669A2 (en) 1986-10-08
ATE72569T1 (de) 1992-02-15
DE3683861D1 (de) 1992-03-26
AU5552486A (en) 1986-10-09
FI861424A0 (fi) 1986-04-02

Similar Documents

Publication Publication Date Title
MX168179B (es) Metodo mejorado para conjugar metalotioneina en moleculas biologicamente activas
BR8801308A (pt) Aparelho e processo para calcular a economia corrigida de combustivel de veiculo
BR8601563A (pt) Processo para a preparacao de esteres alquilicos de acidos carboxilicos com 6 a 24 atomos de carbono,aplicacao e catalisador
DE69031875D1 (de) Zubereitung für die Hämodialyse und deren Produktionsmethode
DE3771650D1 (de) Verfahren zur herstellung von hochreinem 4,6-diamino-1,3-benzoldiol.
IT8620117A1 (it) Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
BR8905529A (pt) Produto intermediario de fabricacao em um transistor bipolar,transistor bipolar de heterojuncao e processo de formacao de um transistor bipolar
NO892486L (no) Surt saapekompleks, samt fremgangsmaate for dets fremstilling.
ES2058293T3 (es) 2,3-dihidroergolinas para mejorar la funcion serotonergica.
DE3872228D1 (de) Elektrode fuer die entwicklung von sauerstoff und deren herstellungsverfahren.
BR9007648A (pt) Processos para preparar hidrocloreto de -apm,e anidrido n-formil-l-aspartico
ES2031511T3 (es) Derivados de platino y tratamientos del cancer.
ATE75487T1 (de) Langwirkende immunotoxine, die eine ribosominaktivierende, an ihren polysaccharidstellen modifizierte glycopeptidsubstanz umfassen.
PT80912B (pt) Processo de preparacao de derivados do lisergol
IT1258315B (it) Derivati del flavone
ATE105286T1 (de) Herstellung von 3,3-diarylacrylsaeureamiden.
DE3466530D1 (de) 2,2-diethoxypropionic acid derivatives
ZA868404B (en) Pharmaceutical compositions for use in improving oxygenation of the brain and a process for their production
ATE27910T1 (de) Topische acylaminophenole.
BE844404A (fr) Nouveaux derives d'acides (&-amino w-(methylenedioxy-2,3phenyl)acylamido)-6 penicillaniques, utiles notamment comme antibiotiques et preparation
IT1230792B (it) Procedimento per aumentare la citotossicita' di antracicline mediante fotoattivazione.
KR960012580B1 (en) Transistor & method of manufacturing the same
CS183483B1 (en) Method for producing mixture of 4,5-dibromsalicylanilide and 3,4,5-tribromsalicylanilide in molecular ratio
HUT46848A (en) Process for producing pharmaceutical composition for topical application
BE862407A (fr) Procede de preparation d'acides 2-aminocyclopentene-1-dithiocarboxyliques substitues sur l'azote utiles comme medicaments